Understanding the Risks of JAK Inhibitors
For several years now Janus Kinase (JAK) inhibitors have been the latest breakthrough in Alopecia Areata treatment. Rather than suppressing the entire
Epigallocatechin-3 Gallate as a Potential Alternative to JAK Inhibitors?
Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients For several years, the big breakthrough in Alopecia Areata research has
Concert Pharmaceuticals Releases Additional Data From Phase 2 Clinical Trial of CTP-543 In Alopecia Areata
In phase 2 of their clinical trial testing the drug CTP-543 (a JAK 1 and JAK 2 inhibitor) as a treatment for